Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, announced a global out-license agreement with AstraZeneca...
Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, announced that, effective on April 1, 2022,...
Evergreen Nephrology is announcing a joint venture with Colorado Kidney Care, a single specialty nephrology practice caring for patients in the greater Denver Metropolitan...
Lytix Biopharma AS, a clinical-stage company with an in situ vaccination technology platform targeting cancer indications, notes that the first patient has been dosed...
